TNF-alpha induces thromboxane receptor signaling-dependent microcirculatory dysfunction in mouse liver

Area of Science:

• Immunology
• Hepatology
• Pharmacology

Background:

• Endotoxemia-induced liver injury involves microcirculatory dysfunction.
• Tumor necrosis factor-alpha (TNF-alpha) is a key mediator in this process.
• The role of thromboxane A2 (TXA2) and its receptor (TP) in TNF-alpha-mediated injury requires elucidation.

Purpose of the Study:

• To investigate the role of TXA2 and TP receptor signaling in TNF-alpha-induced hepatic microcirculatory dysfunction.
• To assess the therapeutic potential of blocking TNF-alpha and TP receptor pathways.

Main Methods:

• In vivo fluorescence microscopy in male C57Bl/6 mice to quantify leukocyte adhesion and nonperfused sinusoids.
• Administration of TNF-alpha inhibitor (FR167653) and TXA2 synthase inhibitor (OKY-046).
• Utilized thromboxane prostanoid (TP) receptor knockout mice to evaluate endogenous TXA2 involvement.

Main Results:

• TNF-alpha significantly increased leukocyte adhesion and hepatic sinusoidal perfusion deficits.
• FR167653 treatment reduced LPS-induced leukocyte adhesion and nonperfused sinusoids.
• OKY-046 and TP receptor knockout attenuated TNF-alpha-induced microcirculatory dysfunction and liver injury markers (ALT).

Conclusions:

• TP receptor signaling exacerbates TNF-alpha-mediated hepatic microcirculatory dysfunction in endotoxemia.
• Blocking TNF-alpha generation and TP receptor signaling presents a promising therapeutic strategy for endotoxin-induced liver injury.